Mariner, LLC Karuna Therapeutics, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $19,804 - $39,095	-123 Reduced 6.07%	1,902 $602,000
Q3 2023 Nov 13, 2023	SELL	$164.66 - $218.08 $7,574 - $10,031	-46 Reduced 2.22%	2,025 $342,000
Q2 2023 Aug 11, 2023	BUY	$176.32 - $240.22 $84,457 - $115,065	479 Added 30.09%	2,071 $449,000
Q1 2023 May 12, 2023	BUY	$161.33 - $204.36 $58,562 - $74,182	363 Added 29.54%	1,592 $289,000
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $235,390 - $291,051	1,229 New	1,229 $241,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.